Company research / STOK
Stoke Therapeutics, Inc. (STOK)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Stoke Therapeutics, Inc. reported revenue of $184.42M. Revenue grew 404.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $27.59M.
Key ratios (year ended 2025-12-31)
-11.2%
Operating margin
-3.7%
Net margin
-2.0%
Return on year-end equity
404.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.